<?xml version="1.0" encoding="UTF-8"?>
<p>Multiplex primer schemes were designed for RABV using 
 <ext-link ext-link-type="uri" xlink:href="http://primal.zibraproject.org/" xmlns:xlink="http://www.w3.org/1999/xlink">Primal Scheme</ext-link>. For Tanzania, a set of 10 reference sequences from datasets curated and filtered in RABV-GLUE were chosen to represent the known RABV diversity in Tanzania (in file order submitted to Primal Scheme: 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/1016870541/" xmlns:xlink="http://www.w3.org/1999/xlink">KR906748.1</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/KR906747.1" xmlns:xlink="http://www.w3.org/1999/xlink">KR906747.1</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/KY210263.1" xmlns:xlink="http://www.w3.org/1999/xlink">KY210263.1</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/KY210264.1" xmlns:xlink="http://www.w3.org/1999/xlink">KY210264.1</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/KY210227.1" xmlns:xlink="http://www.w3.org/1999/xlink">KY210227.1</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/KR906774.1" xmlns:xlink="http://www.w3.org/1999/xlink">KR906774.1</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/KR906763.1" xmlns:xlink="http://www.w3.org/1999/xlink">KR906763.1</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/KR906742.1" xmlns:xlink="http://www.w3.org/1999/xlink">KR906742.1</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/KR534218.2" xmlns:xlink="http://www.w3.org/1999/xlink">KR534218.2</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/KY210305.1" xmlns:xlink="http://www.w3.org/1999/xlink">KY210305.1</ext-link>). Settings were applied to generate primers for 400bp amplicons across the entire genome (~11923bp), with an overlap of 50bp. A short amplicon length was chosen due to previous experience of poor sample quality from field collected and stored samples resulting in RNA fragmentation and a low viral copy number ( 
 <xref rid="ref-17" ref-type="bibr">Brunker 
  <italic>et al.</italic>, 2015
 </xref>; 
 <xref rid="ref-16" ref-type="bibr">Brunker 
  <italic>et al.</italic>, 2018
 </xref>). The first scheme created, rabvTanzDg, was tested on archived Tanzanian RABV RNA samples at APHA following the protocol described in 
 <xref rid="ref-61" ref-type="bibr">Quick 
  <italic>et al.</italic> (2016)
 </xref>. Two sequencing validations were performed: 1) Amplicons from one sample, RV3227, were sequenced on an Illumina NextSeq to confirm the amplification of individual products across the genome. This sample had already been sequenced using a PCR-free metagenomic approach, briefly described in section “Additional Sequencing” (described in 
 <xref rid="ref-17" ref-type="bibr">Brunker 
  <italic>et al.</italic>, 2015
 </xref>), providing a comparison between library preparations; 2) Subsequently, amplicons from another sample (RAB16025) were sequenced on both the MinION and NextSeq (fragmented before sequencing on NextSeq). In addition, metagenomic sequencing was conducted on the NextSeq for this sample. A second RABV scheme was produced for the Philippines (rabvSEasia) following the same approach and used directly for MinION sequencing (reference sequences: 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/KX148260" xmlns:xlink="http://www.w3.org/1999/xlink">KX148260</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/KX148263" xmlns:xlink="http://www.w3.org/1999/xlink">KX148263</ext-link>, N-gene 99% consensus sequence of [ 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/AB116581" xmlns:xlink="http://www.w3.org/1999/xlink">AB116581</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/AB116582" xmlns:xlink="http://www.w3.org/1999/xlink">AB116582</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/AB683592" xmlns:xlink="http://www.w3.org/1999/xlink">AB683592</ext-link>: 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/AB683635" xmlns:xlink="http://www.w3.org/1999/xlink">AB683635</ext-link>], 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/AB981664" xmlns:xlink="http://www.w3.org/1999/xlink">AB981664</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/KX148255" xmlns:xlink="http://www.w3.org/1999/xlink">KX148255</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/JN786878" xmlns:xlink="http://www.w3.org/1999/xlink">JN786878</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/KX148250" xmlns:xlink="http://www.w3.org/1999/xlink">KX148250</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/KX148254" xmlns:xlink="http://www.w3.org/1999/xlink">KX148254</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/EU293111" xmlns:xlink="http://www.w3.org/1999/xlink">EU293111</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/KX148248" xmlns:xlink="http://www.w3.org/1999/xlink">KX148248</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/KX148266" xmlns:xlink="http://www.w3.org/1999/xlink">KX148266</ext-link>).
</p>
